Immune system malfunction is the underlying cause of symptoms in autoimmune, autoinflammatory
and connective tissue disorders.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Atlas of the Oral and Maxillofacial Surgery Clinics of North AmericaAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Autoimmune blistering diseases of the skin.Autoimmun Rev. 2012; 11: 226-230
- Oral mucosal manifestations of autoimmune skin diseases.Autoimmun Rev. 2015; 14: 930-951
- Salivary IgA and IgG antibodies to bullous pemphigoid 180 noncollagenous domain 16a as diagnostic biomarkers in mucous membrane pemphigoid.Br J Dermatol. 2016; 174: 1022-1029
- Future therapies for pemphigus vulgaris: rituximab and beyond.J Am Acad Dermatol. 2016; 74: 746-753
- Serum and salivary IgG and IgA antibodies to desmoglein 3 in mucosal pemphigus vulgaris.Br J Dermatol. 2016; 175: 113-121
- Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group.Arch Dermatol. 1995; 131: 48-52
- Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany.J Dtsch Dermatol Ges. 2009; 7: 434-440
- Ocular and oral mucous membrane pemphigoid (cicatricial pemphigoid).Clin Dermatol. 2012; 30: 34-37
- Mucous membrane pemphigoid and pseudopemphigoid.Ophthalmology. 2004; 111: 45-52
- World Workshop on Oral Medicine VI: a systematic review of the treatment of mucous membrane pemphigoid.Oral Surg Oral Med Oral Pathol Oral Radiol. 2015; 120: 161-171.e20
- Localized oral mucous membrane pemphigoid: successful topical treatment with 1% tacrolimus solution as steroid-sparing therapy.J Eur Acad Dermatol Venereol. 2016; 31: e176-e178
- Efficacy and safety of perilesional/intralesional triamcinolone injections in oral mucous membrane pemphigoid.Br J Dermatol. 2016; 174: 436-438
- The reported prevalence of oral lichen planus: a review and critique.J Oral Pathol Med. 2008; 37: 447-453
- Oral lichen planus: focus on etiopathogenesis.Arch Oral Biol. 2013; 58: 1057-1069
- Lichen planus, lichenoid drug reactions, and lichenoid mucositis.Dent Clin North Am. 2005; 49 (viii): 77-89
- Behcet’s disease physiopathology: a contemporary review.Auto Immun Highlights. 2016; 7: 4
- Behcet’s disease.N Engl J Med. 1999; 341: 1284-1291
- Criteria for diagnosis of Behcet’s disease. International study group for Behcet’s disease.Lancet. 1990; 335: 1078-1080
- The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.J Eur Acad Dermatol Venereol. 2014; 28: 338-347
- The prevalence of oral mucosal lesions and related factors in 188 patients with systemic lupus erythematosus.Lupus. 2012; 21: 1312-1315
- Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program.Arthritis Rheumatol. 2014; 66: 369-378
- Oral manifestations of patients with lupus erythematosus.Dent Clin North Am. 2005; 49 (ix): 127-141
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I.Arthritis Rheum. 2008; 58: 15-25
- Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases.Autoimmun Rev. 2015; 14: 670-679
- Salivary gland pathology in Sjogren’s syndrome.Rheum Dis Clin North Am. 2016; 42: 473-483
- 2016 American College of Rheumatology/European League against Rheumatism classification criteria for primary Sjogren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts.Ann Rheum Dis. 2017; 76: 9-16
- Treatment guidelines for rheumatologic manifestations of Sjogren’s: use of biologics, management of fatigue and inflammatory musculoskeletal pain.Arthritis Care Res (Hoboken). July 2016; 69: 517-527
- Clinical practice guidelines for oral management of Sjogren disease: dental caries prevention.J Am Dent Assoc. 2016; 147: 295-305
- Rheumatoid arthritis.Lancet. 2016; 388: 2023-2038
- Dentition status and temporomandibular joint disorders in patients with rheumatoid arthritis.Cranio. 2002; 20: 165-171
- Temporomandibular disorders in patients with rheumatoid arthritis: a clinical study.Niger J Clin Pract. 2016; 19: 715-720
- Morbidity and mortality in sarcoidosis.Curr Opin Pulm Med. 2014; 20: 472-478
Orphanet report series. Prevalence of rare diseases: Bibliographic data. November 2016, Number 1. Available at: http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf. Accessed May 24, 2017.
- Unexpectedly high prevalence of sarcoidosis in a representative U.S. Metropolitan population.Respir Med. 2012; 106: 893-899
- Sarcoidosis.Lancet. 2014; 383: 1155-1167
NHLBI workshop on sarcoidosis. Leveraging scientific advancements to understand sarcoidosis variability and improve outcomes. August 31st – September 1st 2015. Available at: https://www.nhlbi.nih.gov/research/reports/nhlbi-workshop-sarcoidosis-%E2%80%9Cleveraging-scientific-advancements-understand-sarcoidosis-variability. Accessed May 24, 2017.
- Correlation of MR imaging findings and clinical manifestations in neurosarcoidosis.AJNR Am J Neuroradiol. 2009; 30: 953-961
Article info
Footnotes
No disclosures.
Identification
Copyright
© 2017 Elsevier Inc. All rights reserved.
